Literature DB >> 20522088

The epidemiology of dementia associated with Parkinson's disease.

Dag Aarsland1, Martin Wilhelm Kurz.   

Abstract

Parkinson's disease (PD) is the second most common neurodegenerative illness after Alzheimer's disease (AD). Cognitive impairment and dementia are common features in PD and characterized by a wide range of cognitive deficits distinct from those seen in AD. Mild cognitive impairment occurs even early in PD and is associated with shorter time to dementia. The purpose of this review is to present recent findings on clinical aspects of dementia in PD and to elucidate underlying clinical and neurobiological risk factors.

Entities:  

Mesh：

Year:  2010        PMID： 20522088     DOI： 10.1111/j.1750-3639.2009.00369.x

Source DB:  PubMed          Journal:  Brain Pathol        ISSN： 1015-6305            Impact factor:   6.508


  80 in total

1.  The Movement Disorders Society criteria for the diagnosis of Parkinson's disease dementia: their usefulness and limitations in elderly patients.

Authors:  Michèle Kiesmann; Jean-Baptiste Chanson; Julien Godet; Thomas Vogel; Laetitia Schweiger; Saïd Chayer; Georges Kaltenbach
Journal:  J Neurol       Date:  2013-07-09       Impact factor: 4.849

2.  Partial depletion of striatal dopamine enhances penetrance of cognitive deficits in a transgenic mouse model of Alzheimer's disease.

Authors:  Erica J Melief; Eiron Cudaback; Nikolas L Jorstad; Emily Sherfield; Nadia Postupna; Angela Wilson; Martin Darvas; Kathleen S Montine; C Dirk Keene; Thomas J Montine
Journal:  J Neurosci Res       Date:  2015-03-30       Impact factor: 4.164

Review 3.  Dementia with Lewy bodies and Parkinson's disease-dementia: current concepts and controversies.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2017-12-08       Impact factor: 3.575

Review 4.  PET Imaging in Movement Disorders.

Authors:  Baijayanta Maiti; Joel S Perlmutter
Journal:  Semin Nucl Med       Date:  2018-08-16       Impact factor: 4.446

Review 5.  Adenosine kinase: exploitation for therapeutic gain.

Authors:  Detlev Boison
Journal:  Pharmacol Rev       Date:  2013-04-16       Impact factor: 25.468

6.  Predictors of dementia in Parkinson disease: a prospective cohort study.

Authors:  Julius B M Anang; Jean-Francois Gagnon; Josie-Anne Bertrand; Silvia Rios Romenets; Veronique Latreille; Michel Panisset; Jacques Montplaisir; Ronald B Postuma
Journal:  Neurology       Date:  2014-08-29       Impact factor: 9.910

7.  APOE, MAPT, and COMT and Parkinson's Disease Susceptibility and Cognitive Symptom Progression.

Authors:  Kimberly C Paul; Rebecca Rausch; Michelle M Creek; Janet S Sinsheimer; Jeff M Bronstein; Yvette Bordelon; Beate Ritz
Journal:  J Parkinsons Dis       Date:  2016-04-02       Impact factor: 5.568

8.  Frontal and posterior subtypes of neuropsychological deficit in Parkinson's disease.

Authors:  Ivy N Miller; Sandy Neargarder; Megan M Risi; Alice Cronin-Golomb
Journal:  Behav Neurosci       Date:  2013-02-11       Impact factor: 1.912

9.  Default mode network differences between rigidity- and tremor-predominant Parkinson's disease.

Authors:  Prasanna R Karunanayaka; Eun-Young Lee; Mechelle M Lewis; Suman Sen; Paul J Eslinger; Qing X Yang; Xuemei Huang
Journal:  Cortex       Date:  2016-05-06       Impact factor: 4.027

Review 10.  Mild cognitive impairment in Parkinson's disease.

Authors:  Amos D Korczyn
Journal:  J Neural Transm (Vienna)       Date:  2013-03-19       Impact factor: 3.575
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.